Clinical Trial

Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Background: The retina is a thin layer of tissue at the back of the eye. Retinal disease usually reduces a person s mobility because it affects how he or she moves through familiar and unfamiliar environments. Researchers want to see if a virtual reality (VR) tool can provide an easier and more accurate way to assess mobility. Objective: To learn if researchers can track changes in mobility in people with retinal disease using a new VR tool. Eligibility: People aged 5 and older with retinal disease that affects their vision, and healthy volunteers. Design: Participants will have 2-3 clinic visits. Participants will wear goggles or sit in front of a screen while sitting. Using a game controller, they will navigate through 4 obstacle courses presented in VR. Participants will have a medical history exam. They will answer questions about their family history. They will fill out questionnaires about the vision and mobility issues they have in their daily lives. Participants will have a complete eye exam. They will read letters from a chart. Their eye pressure will be measured. Their pupils may be dilated with eye drops. Pictures of their eye will be taken. Lights will be shined in their eyes. Participants will take a visual field test. For this, they will look into a dome and press a button when they see a light. Participants will have an electroretinogram. For this, they will sit in the dark with their eyes patched. Then their eyes will be numbed with eye drops and they will wear contact lenses while watching flashing lights. Participants will have optical coherence tomography. This is a noninvasive procedure. It produces cross-sectional pictures of the retina....
Protocol Amendment History 624 amendments
This ClinicalTrials.gov record has been amended 624 times since 2020-02-27; most recent amendment 2026-07-08.
Status change: Not Yet Recruiting → Recruiting 2022-10-03
Status change: Recruiting → Not Yet Recruiting 2021-10-27
Trial Details
NCT Number NCT04289571
Lead Sponsor National Eye Institute (NEI)
Conditions Cone-Rod Degeneration, Rod-Cone Degeneration
Enrollment 165 participants
Start Date 2023-07-25
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-10